Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk
Open Access
- 28 October 2003
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 89 (9), 1697-1704
- https://doi.org/10.1038/sj.bjc.6601312
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prediagnostic levels of C‐peptide, IGF‐I, IGFBP ‐1, ‐2 and ‐3 and risk of endometrial cancerInternational Journal of Cancer, 2003
- Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.2002
- Energy balance and cancer: the role of insulin and insulin-like growth factor-IProceedings Of The Nutrition Society, 2001
- Overweight as an avoidable cause of cancer in EuropeInternational Journal of Cancer, 2000
- Organochlorines and endometrial cancer risk.2000
- Risk of Endometrial Cancer Following Estrogen Replacement With and Without ProgestinsJNCI Journal of the National Cancer Institute, 1999
- Use of oral contraceptives and endometrial cancer risk (Sweden)Cancer Causes & Control, 1999
- Insulin-like Growth Factor Binding Protein-1: Recent Findings and New DirectionsExperimental Biology and Medicine, 1997
- Insulin and Endometrial CancerAmerican Journal of Epidemiology, 1997
- Affinity chromatography with amniotic fluid somatomedin binding protein in the purification of insulin-like growth factor IBiochemical and Biophysical Research Communications, 1986